Advanced Prostate Cancer VL

Plasma based Biomarkers in Advanced Prostate Cancer - Gerhardt Attard

Details
Gerhardt Attard focuses on DNA Plasma-based biomarkers in advanced prostate cancer (16 minute presentation). He presents the rationale for using plasma DNA. Plasma collection is routine and are adding to the registries allows for ongoing clinical trials. Circulating tumor DNA is detected in plasma from ALL progressing mCRPC patients. Plasma DNA is representative of clinically relevant progressing...

APCCC 2017: Interview With Howard Soule

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage A Look at the Prostate Cancer Foundation Its History and Contributions to Medical Progress: Interview with Stuart Holden

ADT Impact on Cardiovascular Health - Jehonathan Pinthus

Details
The impact of androgen deprivation therapy (ADT) on cardiovascular health Biographies: Thomas E. Keane Jehonathan H. Pinthus, MD, PhD, FRCSC is a surgical oncologist-urologist and ssociate Professor in the Department of Surgery Division of Urology McMaster University. He is heading a basic and translational research laboratory at McMaster University and his research interests relates to the patien...

Patient-Reported Outcomes (PROs): Personalizing Care in Clinical Practice - Alicia Morgans

Details
Patient-Reported Outcomes (PRO): Personalizing Care in Clinical Practice Biography: Alicia Morgans, MD, MPH Related Content: Tools for predicting patient-reported outcomes (PROs): Optimizing Use in Clinical Practice

Using Biomarkers to Determine When Biopsy and When to Repeat the Biopsy- Stephen Williams

Details
Using Biomarkers to determine When Biopsy and When to Repeat the Biopsy: PSA, PHI, 4K, PCA3 and Confirm MDx Biography: Stephen B. Williams, MD Assistant Professor in Urology, Tenure-Track Robert Earl Cone Professorship Director of Urologic Oncology Director of Urologic Research Co-Director Department of Surgery Clinical Outcomes Research Program

Active Surveillance: Protecting Patients From Harm- Laurence Klotz

Details
Protecting Patients From Harm - Active Surveillance Biographies: Thomas E Keane Laurence Klotz, MD Related Content: Active Surveillance in PCa+ Active surveillance in prostate cancer: a critical review

IRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cancer- Lorelei Mucci

Details
IRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cancer Biographies: Alicia Morgans, MD, MPH Lorelei Mucci, ScD, MPH Also check out Lorelei Mucci & Philip Kantoff on Outcomes Research and the IRONMAN Project

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer - Stacy Loeb

Details
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer - Journal of Clinical Oncology Biographies: Alicia Morgans Stacy Loeb, MD, is an Assistant Professor of Urology and Population Health at New York University (NYU), specializing in prostate cancer and men's health. She has a K07 grant from the National Cancer Institute to study active surveillance for prostate can...

Debate: Comparative Effectiveness of Surgery versus Radiation- Laurence Klotz

Details
The following presentation was made at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between the 14th and 16th October. Laurence Klotz, MD and Mack Roach, III , MD presented a debate on “Comparative Effectiveness of Surgery and Radiation: Surgery Is Better” versus “Radiotherapy Yields Better Oncologic Outcomes than Radical Prostatectomy for Clin...